Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Olga Gusyatiner"'
Autor:
Alessandro Tancredi, Olga Gusyatiner, Pierre Bady, Michelle C. Buri, Rémy Lomazzi, Davide Chiesi, Mahmoud Messerer, Monika E. Hegi
Publikováno v:
Cell Death and Disease, Vol 13, Iss 12, Pp 1-12 (2022)
Abstract Bromodomain and extra-terminal tail (BET) proteins have been identified as potential epigenetic targets in cancer, including glioblastoma. These epigenetic modifiers link the histone code to gene transcription that can be disrupted with smal
Externí odkaz:
https://doaj.org/article/f2a9f26c12994f11b4a43ca841fb4d30
Autor:
Cristina Cudalbu, Pierre Bady, Marta Lai, Lijing Xin, Olga Gusyatiner, Marie-France Hamou, Mario Lepore, Jean-Philippe Brouland, Roy T. Daniel, Andreas F. Hottinger, Monika E. Hegi
Publikováno v:
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-16 (2021)
Abstract The invasive behavior of glioblastoma, the most aggressive primary brain tumor, is considered highly relevant for tumor recurrence. However, the invasion zone is difficult to visualize by Magnetic Resonance Imaging (MRI) and is protected by
Externí odkaz:
https://doaj.org/article/a416de5d02cb4615927e075f26e510a2
Autor:
Mor Mishkovsky, Olga Gusyatiner, Bernard Lanz, Cristina Cudalbu, Irene Vassallo, Marie-France Hamou, Jocelyne Bloch, Arnaud Comment, Rolf Gruetter, Monika E. Hegi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Glioblastoma (GBM) is the most aggressive brain tumor type in adults. GBM is heterogeneous, with a compact core lesion surrounded by an invasive tumor front. This front is highly relevant for tumor recurrence but is generally non-detectable
Externí odkaz:
https://doaj.org/article/63f02f86298445728f1acfcb8546e62d
Autor:
Arnaud Comment, Olga Gusyatiner, Bernard Lanz, Jocelyne Bloch, Irene Vassallo, Marie-France Hamou, Mor Mishkovsky, Rolf Gruetter, Monika E. Hegi, Cristina Cudalbu
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific reports, vol. 11, no. 1, pp. 5771
Scientific reports, vol. 11, no. 1, pp. 5771
Glioblastoma (GBM) is the most aggressive brain tumor type in adults. GBM is heterogeneous, with a compact core lesion surrounded by an invasive tumor front. This front is highly relevant for tumor recurrence but is generally non-detectable using sta
Autor:
Hyeok Choi, Woo Jong Cho, Olga Gusyatiner, Pierre Bady, Manuel Bueno, Roy Daniel, Keith Harshman, Julien Marquis, Monika Hegi, Leeyoung Park
Publikováno v:
WFNOS 2022 Abstract Book.
Autor:
Alessandro Tancredi, Olga Gusyatiner, Pierre Bady, Michelle Buri, Rémy Lomazzi, Davide Chiesi, Monika Hegi
Publikováno v:
Neuro-Oncology. 24:vii91-vii91
Bromodomain and extra-terminal tail (BET) proteins have been identified as potential epigenetic targets in cancer, including glioblastoma. These epigenetic modifiers link the histone code to gene transcription that can be disrupted with small molecul
Autor:
Jean-Philippe Brouland, Cristina Cudalbu, Lijing Xin, Andreas F. Hottinger, Roy Thomas Daniel, Monika E. Hegi, Pierre Bady, Marta Lai, Olga Gusyatiner, Mario Lepore, Marie-France Hamou
Publikováno v:
Acta neuropathologica communications, vol. 9, no. 1, pp. 133
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-16 (2021)
Acta Neuropathologica Communications
BioRxiv
Acta Neuropathologica Communications, Vol 9, Iss 1, Pp 1-16 (2021)
Acta Neuropathologica Communications
BioRxiv
The invasive behavior of glioblastoma, the most aggressive primary brain tumor, is considered highly relevant for tumor recurrence. However, the invasion zone is difficult to visualize by Magnetic Resonance Imaging (MRI) and is protected by the blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7278226f5c798527e12857fb894c162
https://serval.unil.ch/notice/serval:BIB_CB8B36AE633E
https://serval.unil.ch/notice/serval:BIB_CB8B36AE633E
Autor:
Minh Diêu Thanh Pham, Olga Gusyatiner, Mauro Delorenzi, Yvonne Lei, Monika E. Hegi, Roy Thomas Daniel, Pierre Bady, Jungyeon Park
Publikováno v:
Neuro-Oncology
Neuro-oncology, vol. 23, no. 10, pp. 1680-1692
Neuro-oncology, vol. 23, no. 10, pp. 1680-1692
Background The development of rational combination therapies is key to overcome inherent treatment resistance of glioblastoma (GBM). We aim at identifying new druggable targets by disturbing GBM cells with inhibitors of bromodomain and extra-terminal
Autor:
Mor, Mishkovsky, Olga, Gusyatiner, Bernard, Lanz, Cristina, Cudalbu, Irene, Vassallo, Marie-France, Hamou, Jocelyne, Bloch, Arnaud, Comment, Rolf, Gruetter, Monika E, Hegi
Publikováno v:
Scientific Reports
Glioblastoma (GBM) is the most aggressive brain tumor type in adults. GBM is heterogeneous, with a compact core lesion surrounded by an invasive tumor front. This front is highly relevant for tumor recurrence but is generally non-detectable using sta
Autor:
Jean-Philippe Brouland, Marie-France Hamou, Monika E. Hegi, Pierre Bady, Cristina Cudalbu, Roy Thomas Daniel, Marta Lai, Andreas F. Hottinger, Lijing Xin, Olga Gusyatiner, Mario Lepore
Publikováno v:
Neuro-oncology Advances
Background The invasive behavior of glioblastoma is considered highly relevant for recurrence. However, the invasion zone is difficult to visualize, typically lies outside the resected and irradiated area, and is protected by the blood brain barrier,